Overview
Portfolio
More
Biomedvc
Basel, Switzerland
Focus on early‑stage biotech and health‑related startups, leveraging scientific breakthroughs to create impactful medicines.
Portfolio
62+
Employees
5+
Founded
N/A
AUM
≈ $236.9M
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
Switzerland
Fund details
Funds
BioMedInvest II
Vintage 2009 • $121.9M
BioMedInvest III
Vintage 2017 • $115.0M
Sources
Biomedvc
Focus on early‑stage biotech and health‑related startups, leveraging scientific breakthroughs to create impactful medicines.
Portfolio
62+
Employees
5+
Founded
N/A
AUM
≈ $236.9M
Funds
BioMedInvest II · Vintage 2009 • $121.9M
BioMedInvest III · Vintage 2017 • $115.0M
Stages
No stages listed
Industries
No industries listedGeographic scope
Switzerland
Sources
Showing 18 of 18 matched portfolio companies
ALENTIS Therapeutics develops anti-Claudin-1 monoclonal antibodies and antibody-drug conjugates to treat cancer and reverse fibrosis by targeting Claudin-1 to disrupt disease signaling and selectively kill tumor cells. Their clinical pipeline includes candidates for solid tumors and organ fibrosis, addressing significant unmet medical needs in advanced liver disease and various cancers.
Azafaros develops therapeutic agents that target rare metabolic disorders through metabolic pathway modulation and advanced drug discovery techniques. The company provides effective treatment options for patients with unmet medical needs in this specialized healthcare segment.
Cardior Pharmaceuticals develops non-coding RNA-based therapeutics, specifically CDR132L, to reverse adverse cardiac remodeling in heart failure patients following myocardial infarction. Their approach targets the underlying mechanisms of heart disease, aiming to restore normal cellular functions and improve patient outcomes.
Cord offers APIs and UI components that let developers embed real-time chat, comments, and activity feeds directly into their web applications. The platform handles message delivery, presence detection, moderation, and analytics, providing SDKs for popular JavaScript frameworks and REST/WebSocket integration so product teams can add in‑app communication without building the infrastructure themselves.
Funding: $20.1M
Rough estimate of the amount of funding raised
Funding: $20.1M
Rough estimate of the amount of funding raised
HARM provides an AI-powered platform for individuals experiencing harm to quickly access immediate, trusted support. The system intelligently identifies the nature of the reported harm and routes users directly to appropriate, city-approved advocacy, legal, or housing resources. This streamlined process eliminates confusion while generating de-identified data insights to help municipal leaders optimize community support services.
ImmunOs Therapeutics develops bispecific antibody immunotherapies that direct a patient’s immune system to target cancer cells and inflammatory disease antigens. Their lead candidate, IOS‑1002, combines engineered binding domains and an optimized Fc region to enhance specificity, potency, and half‑life, and is currently in Phase 1 trials, including combination studies with checkpoint inhibitors. The platform aims to provide pharmaceutical partners and clinicians with next‑generation, combination‑ready treatments for solid tumors and rheumatic diseases.
Funding: $11.0M
Rough estimate of the amount of funding raised
Funding: $11.0M
Rough estimate of the amount of funding raised
Klim provides tailored Scope 3 solutions for agricultural supply chains by implementing regenerative farming practices that enhance soil carbon sequestration and improve biodiversity. The platform supports farmers with financial incentives and guidance, while helping companies achieve their carbon reduction goals through verified local CO₂ certificates.
Lev is a commercial mortgage marketplace that utilizes real-time lender data and an AI-powered matching algorithm to streamline the financing process for capital market advisors. The platform enables sponsors and brokers to efficiently identify suitable lenders, manage deals, and automate follow-ups, significantly reducing the time and effort required to secure financing.
Luma provides a platform for easily setting up event pages, managing invitations, and selling tickets for various gatherings. The service streamlines the process of hosting memorable events from creation to execution. Users can quickly launch and promote their events directly through the platform's interface.
Funding: $3.0M
Rough estimate of the amount of funding raised
Funding: $3.0M
Rough estimate of the amount of funding raised
Noema Pharma is a clinical-stage biotech company developing disease-modifying therapeutics for central nervous system conditions, including persistent seizures, severe pain, and involuntary tics. Their therapies aim to improve the quality of life for patients with both rare and common neurological disorders by targeting the underlying symptoms rather than merely managing them.
Funding: $209.8M
Rough estimate of the amount of funding raised
Funding: $209.8M
Rough estimate of the amount of funding raised
ON is an AI chat platform designed for enterprise use, integrating with e-commerce systems like Shopify to enhance customer interactions by providing real-time access to product and order information. This technology addresses the high volume of customer service inquiries, improving site conversions and customer satisfaction while reducing the workload for support agents.
Funding: $25.0M
Rough estimate of the amount of funding raised
Funding: $25.0M
Rough estimate of the amount of funding raised
One is a financial technology platform that offers mobile banking services, including high-yield savings accounts with a 4.35% APY, early direct deposit, and cash back rewards at select retailers. The platform addresses the need for low-cost banking solutions by eliminating monthly fees and providing tools for credit building without interest or credit checks.
Founded 2019
1000+
Approximate amount of employees
Funding: $300.0M
Rough estimate of the amount of funding raised
Funding: $300.0M
Rough estimate of the amount of funding raised
Operates as a direct digital mortgage lender, leveraging proprietary software to automate administrative tasks and streamline the application process. By eliminating middlemen and offering commission-free advisors, it provides lower interest rates and faster pre-approvals, helping customers save on mortgage costs and simplify home financing.
Funding: $21.0M
Rough estimate of the amount of funding raised
Funding: $21.0M
Rough estimate of the amount of funding raised
Precirix is developing precision radiopharmaceuticals that utilize camelid single-domain antibodies labeled with radiometals to target Fibroblast Activation Protein (FAP) in cancer treatment. This approach aims to provide a first-in-class alpha-emitting targeted radiotherapy for a broad range of tumors, addressing the need for more effective cancer therapies.
RA UNLIMITED harnesses solar photovoltaic technology to generate clean and affordable electricity for homes, businesses, and communities in the Philippines. The company addresses the reliance on fossil fuels by providing sustainable energy solutions that create jobs and enhance the quality of life for Filipinos.
Scenic Biotech develops genomics and immunotherapy technologies to identify and utilize genetic suppressors for therapeutic applications. Their platform targets disease pathways in neuro- and metabolic disorders, enabling the creation of disease-modifying therapies that offer new treatment options for patients.
Funding: $31.0M
Rough estimate of the amount of funding raised
Funding: $31.0M
Rough estimate of the amount of funding raised
Tolremo is a company whose specific product or service details are not available from the provided source.
Vendy provides a commerce platform that integrates directly within messaging applications like WhatsApp to simplify the sales process for businesses. The service enables sellers to create a virtual shop, manage inventory, and issue automatic invoices directly through the chat interface. Vendy facilitates secure in-app payments and automates both physical and digital product fulfillment for buyers.
Funding: $1.2M
Rough estimate of the amount of funding raised
Funding: $1.2M
Rough estimate of the amount of funding raised
Showing 12 of 44 unmatched portfolio companies